Compared to patients who never used the drug, current users of ACEI, ARB, statin, warfarin, direct factor Xa inhibitors and P2Y12 inhibitors were associated with decreased risk of contracting COVID-19, ranging from 1% reduction (direct factor Xa inhibitors) to 12% reduction (warfarin). The gene discussed is F10; the disease is COVID-19.